Biotech Pharmaceutical
Progenra, Inc works to find new medicines for a variety of diseases through the ubiquitin pathway, a critical mechanism of cellular regulation. Dedicated to finding new medicines for a variety of diseases through the ubiquitin pathway, a critical mechanism of cellular regulation. Progenra's assay platform and unique profiling capacity can identify selective inhibitors of critical ubiquitin pathway enzymes associated with cancer, osteoporosis, and other debilitating diseases. This technology and multiple selective compounds are available for licensing.